SEC Form 4 · accession 0001209191-18-007139
NEKTAR THERAPEUTICS · NKTR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Nicholson
Officer — SVP & Chief Operating Officer
Period of report
Jan 31, 2018
Accepted (ET)
Feb 2, 2018 · 6:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000906709
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 31, 2018 | M | 120,000 | $11.34 | A | 392,536 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $11.34 | Jan 31, 2018 | M | 120,000 | D | Feb 1, 2014 | Feb 1, 2018 | Common Stock | 120,000 | 0 | D |
Explanation of responses
- F1This transaction was made for stock options scheduled to expire on February 1, 2018.